Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. [electronic resource]
Producer: 20080801Description: 370-82 p. digitalISSN:- 1352-4585
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Anti-Inflammatory Agents -- administration & dosage
- Cooperative Behavior
- Data Interpretation, Statistical
- Disability Evaluation
- Drug Therapy, Combination
- Female
- Humans
- Immunosuppressive Agents -- administration & dosage
- Interferon beta-1a
- Interferon-beta -- administration & dosage
- Magnetic Resonance Imaging
- Male
- Methotrexate -- administration & dosage
- Methylprednisolone -- administration & dosage
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Patient Selection
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.